Telomir Pharmaceuticals, Inc. Common Stock
General ticker "TELO" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $81.4M (TTM average)
Telomir Pharmaceuticals, Inc. Common Stock does not follow the US Stock Market performance with the rate: -19.5%.
Estimated limits based on current volatility of 2.5%: low 1.35$, high 1.42$
Factors to consider:
- Total employees count: 15 as of 2023
Short-term TELO quotes
Long-term TELO plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $0.85MM | $3.94MM | $12.24MM |
| Operating Income | $-0.85MM | $-3.94MM | $-12.24MM |
| Non-Operating Income | $0.00MM | $-9.13MM | $-4.29MM |
| Interest Expense | $0.00MM | $1.64MM | $4.34MM |
| R&D Expense | $0.83MM | $1.57MM | $2.24MM |
| Income(Loss) | $-0.85MM | $-13.07MM | $-16.53MM |
| Profit(Loss)* | $-0.85MM | $-13.07MM | $-16.53MM |
| Stockholders Equity | $-0.94MM | $3.44MM | $0.64MM |
| Assets | $0.05MM | $4.77MM | $1.32MM |
| Operating Cash Flow | $-0.47MM | $-3.86MM | $-5.07MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $0.47MM | $3.86MM | $6.34MM |
| Earnings Per Share** | $-0.03 | $-0.44 | $-0.56 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.